VAC Q3 Earnings Call: Contract Sales Surge 29%, Outlook Raised, But Leverage Concerns Persist

What happened

Marriott Vacations Worldwide (VAC) delivered a sharp inflection in its fiscal third quarter, as contract sales jumped 29% year-over-year and development profit improved enough to warrant raising full-year guidance for both contract sales and adjusted earnings. The strong quarter contrasts with the prior 3Q25 report, where contract sales fell 4% and VPG declined 5%, indicating management's turnaround efforts may be gaining traction. The company attributed the improvement to better tour monetization and sales execution, though details from the earning call transcript are still emerging. While the operating momentum is encouraging, the balance sheet remains a key risk: S&P recently downgraded VAC to 'B+' with a negative outlook, and leverage is expected to stay above 5.5x through end-2026. Additionally, the heavy modernization spend (~$100M cash costs in both 2025 and 2026) continues to pressure free cash flow, even as the company seeks to reduce its debt load.

Implication

The 29% contract sales growth and raised outlook directly address the core bear concern that VAC's sales engine was failing to stabilize. However, the report must be scrutinized for quality: the growth may be flattered by easy comparisons, one-time factors, or lower-margin sales, given that development profit improved but margin details are not yet clear. Investors should also monitor whether the company finally lowers its sales reserve, which has been a persistent drag on GAAP margins; management previously said it would need sustained evidence of improved credit performance. Balance sheet risk remains the primary impediment to a re-rating: with net debt/EBITDA around 8x per latest financials, any hiccup in cash generation or securitization access could trigger further downgrades or covenant stress. Overall, the bull case is strengthened but not proven; a more disciplined entry would be to wait for confirmation in next quarter's KPIs (VPG, tours, margin) and signs that leverage is declining before upgrading from WAIT to BUY.

Thesis delta

The prior WAIT thesis was based on expectations of KPI stabilization only by mid-2026; today's news pulls that inflection forward, implying the bull scenario (20% probability) may be understated. However, the balance sheet overhang and modernization cash costs prevent a full shift to bullish conviction, as the company still needs to demonstrate sustained improvement and deleveraging. The thesis changes from "show-me story with high downside" to "early evidence of turnaround with lingering financial risk," but the rating remains WAIT until more data confirms the trend.